Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.10
+0.06 (0.85%)
At close: Apr 28, 2026, 4:00 PM EDT
6.89
-0.21 (-2.96%)
After-hours: Apr 28, 2026, 7:34 PM EDT
Precision BioSciences Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Precision BioSciences stock have an average target of 45, with a low estimate of 30 and a high estimate of 60. The average target predicts an increase of 533.80% from the current stock price of 7.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Precision BioSciences stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +322.54% | Apr 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +745.07% | May 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +745.07% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +745.07% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +745.07% | Feb 19, 2025 |
Financial Forecast
Revenue This Year
13.34M
from 34.26M
Decreased by -61.08%
Revenue Next Year
13.16M
from 13.34M
Decreased by -1.34%
EPS This Year
-3.23
from -3.56
EPS Next Year
-2.76
from -3.23
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 31.1M | 25.5M | ||||||
| Avg | 13.3M | 13.2M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -9.3% | 91.3% | ||||||
| Avg | -61.1% | -1.3% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -2.17 | -1.32 | ||||
| Avg | -3.23 | -2.76 | ||||
| Low | -4.31 | -3.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.